Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PML in a patient treated with dimethyl fumarate from a compounding pharmacy.

Literature DB >> 23614604

PML in a patient treated with dimethyl fumarate from a compounding pharmacy.

Bob W van Oosten, Joep Killestein, Frederik Barkhof, Chris H Polman, Mike P Wattjes.

Abstract

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 2013 PMID： 23614604 DOI： 10.1056/NEJMc1215357

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

77 in total

Review 1. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors: Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal: Nat Rev Neurol Date: 2015-09-15 Impact factor: 42.937

Review 2. Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Authors: Jens Ingwersen; Orhan Aktas; Hans-Peter Hartung
Journal: Neurotherapeutics Date: 2016-01 Impact factor: 7.620

Review 3. [Immunotherapies for multiple sclerosis : review and update].

Authors: J Havla; T Kümpfel; R Hohlfeld
Journal: Internist (Berl) Date: 2015-04 Impact factor: 0.743

Review 4. Fumaric acid esters for psoriasis: a systematic review.

Authors: D Smith
Journal: Ir J Med Sci Date: 2016-06-07 Impact factor: 1.568

5. Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases.

Authors: Robert Hoepner; Simon Faissner; Gisa Ellrichmann; Ruth Schneider; Ralf Gold
Journal: Ther Adv Neurol Disord Date: 2014-11 Impact factor: 6.570

6. A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy.

Authors: Salim Chahin; Joseph R Berger
Journal: J Neurovirol Date: 2014-11-18 Impact factor: 2.643

7. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.

Authors: Kenneth R Carson; Scott D Newsome; Ellen J Kim; Nina D Wagner-Johnston; Gloria von Geldern; Craig H Moskowitz; Alison J Moskowitz; Alain H Rook; Pankaj Jalan; Alison W Loren; Daniel Landsburg; Thomas Coyne; Donald Tsai; Dennis W Raisch; LeAnn B Norris; P Brandon Bookstaver; Oliver Sartor; Charles L Bennett
Journal: Cancer Date: 2014-04-25 Impact factor: 6.860